Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer, Gilead, Ross: What to Watch When the Stock Market Opens Today

11/20/2020 | 07:18am EST

By Jem Bartholomew

Here's what we're watching as markets kick into gear Friday.

-- Stock futures wavered near the flatline, putting Wall Street on track to end a choppy week with muted losses. Futures tied to the S&P 500 edged up less than 0.1%, while Dow Jones Industrial Average futures fell 0.1%. Read our full market wrap here.

-- What's coming up. Foot Locker reports earnings this morning. A measure of European consumer confidence is due at 10 a.m. ET, and the Baker Hughes rig count, a proxy for drilling activity in the oil industry, is expected at 1 p.m.

-- IPOs to watch. Maravai LifeSciences Holdings and Sotera Health are expected to begin trading Friday.

-- Pfizer said it plans to ask U.S. health regulators on Friday to permit use of its Covid-19 vaccine, a milepost in months of frantic efforts to find a medicine that could beat back a rampaging pandemic. It could put the vaccine on track for distribution in December if cleared quickly. The pharmaceutical company's shares climbed 1.8% in offhours trading.

Market Movers to Watch

-- Gilead Sciences fell 2.3% before the bell after the World Health Organization recommended against the use of antiviral drug remdesivir for Covid-19.

-- Moderna, another company in the race for a coronavirus vaccine, saw its shares climb premarket more than 4%.

-- Ross Stores surged 4.4% offhours after the retailer posted third-quarter earnings that beat analysts' predictions.

-- Workday dropped 4% premarket after the cloud-software company warned of lingering Covid-19 effects, despite reporting profit and revenue that topped Wall Street's expectations.

Must Reads Since You Went to Bed

With Covid-19 Pandemic Dragging On, Some Countries Say They Can't Afford to Fight

Will Political Polarization Stop Companies From Supporting Social Causes?

Job Market Growth Slows Across U.S. as Covid-19 Cases Surge

Lumber Prices Rise Again, Defying the Normal Seasonal Slowdown

Brexit: What You Need to Know About the U.K.'s Prospective Deal With the EU

Suffering Emerging Markets Can Bounce Back From the Depths

(END) Dow Jones Newswires

11-20-20 0717ET

Stocks mentioned in the article
ChangeLast1st jan.
BAKER HUGHES COMPANY -0.97% 20.41 Delayed Quote.-1.15%
DJ INDUSTRIAL -2.05% 30303.17 Delayed Quote.1.16%
EURO / BRITISH POUND (EUR/GBP) -0.06% 0.88426 Delayed Quote.-0.60%
FOOT LOCKER, INC. -7.02% 43.18 Delayed Quote.16.77%
GILEAD SCIENCES, INC. -1.83% 65.48 Delayed Quote.14.49%
LONDON BRENT OIL -0.93% 55.54 Delayed Quote.7.08%
MODERNA, INC. 2.50% 155.73 Delayed Quote.45.35%
NASDAQ 100 -2.80% 13112.649836 Delayed Quote.4.62%
NASDAQ COMP. -2.61% 13270.597569 Delayed Quote.5.08%
PFIZER INC. -2.87% 36.24 Delayed Quote.1.36%
ROSS STORES, INC. -3.38% 107.89 Delayed Quote.-7.55%
S&P 500 -2.57% 3750.77 Delayed Quote.2.49%
WTI -0.27% 52.611 Delayed Quote.8.49%
All news about PFIZER INC.
05:52pPFIZER : Tensions rise as AstraZeneca, EU spar over vaccine delays
05:47pCELCUITY : Unveils Research Collaboration With Sarah Cannon Research Institute, ..
03:58pEU Clashes With AstraZeneca Over Covid-19 Vaccine Shortfall
03:36pEU health official blasts slow vaccine delivery, and is consulting with Canad..
02:48pRussia warns of delays in Sputnik V vaccine supply to Latin America
02:46pPFIZER : Canada scrambling for smaller syringes ahead of expected Pfizer vaccine..
02:33pWHO Recommends Against Moderna, Pfizer Vaccines for Most Pregnant Women
12:54pOxford scientists expect some vaccine data on UK mutant virus by next week
10:40aFrance's Sanofi to help rival Pfizer-BioNTech make vaccines
10:15aPFIZER : States lift restrictions gradually amid fears of new variant
More news
Financials (USD)
Sales 2020 46 470 M - -
Net income 2020 17 722 M - -
Net Debt 2020 43 412 M - -
P/E ratio 2020 14,4x
Yield 2020 3,90%
Capitalization 207 B 207 B -
EV / Sales 2020 5,40x
EV / Sales 2021 4,31x
Nbr of Employees 88 300
Free-Float 59,1%
Duration : Period :
Pfizer Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 41,71 $
Last Close Price 37,31 $
Spread / Highest target 42,1%
Spread / Average Target 11,8%
Spread / Lowest Target -3,51%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Suzanne Nora Johnson Independent Director
Helen H. Hobbs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC.1.36%207 384
JOHNSON & JOHNSON8.32%448 796
ROCHE HOLDING AG4.51%312 213
NOVARTIS AG0.81%214 457
MERCK & CO., INC.-1.89%203 035